Abstract

To address the problem of incentive spirometry (IS) noncompliance, a use-tracking IS reminder device (SpiroTimer™) was developed. In a recent randomized clinical trial, the SpiroTimer™ improved IS use compliance, length of stay, and mortality. For successful, safe, and effective implementation of a new medical device, human factors and usability must be evaluated. This study aims to evaluate the SpiroTimer™'s human factors as they pertain to intended users, use environments, and uses. Immediately following the completion of the randomized clinical trial of the SpiroTimer™, before the providers were informed of the results of the study, a human factors and usability survey was distributed in-person to all nurses involved in the trial. Variations in nurse user perspectives were evaluated. A total of 52 nurses (100% response rate) completed the survey. In general, most nurses felt IS use compliance is poor (65%; 34/52, p = 0.0265) and should be improved (94%; 49/52, p < 0.001). Nurses agreed the SpiroTimer™ ameliorated patient IS use compliance (82%; 41/50, p < 0.001), IS effectiveness (74 %; 37/50, p < 0.001), and patient engagement in their own care (88%; 44/ 50, p < 0.001). Nurses reported the SpiroTimer™ helped remind them to work with their patients on IS (70%; 35/50, p = 0.0047) while reducing the number of times they had to remind their patients to use their IS (70%; 35/50, p = 0.0047). They felt that they would use the SpiroTimer™ with all their patients (82%; 41/50, p < 0.001) and that they would recommend the SpiroTimer™ to a colleague (74%; 37/50, p < 0.001). Ultimately, most nurses believed the SpiroTimer™ should become part of routine patient care (78%; 39/50, p < 0.001). For a new medical technology to a medical device to be effectively implemented, human factors and usability must be demonstrated. Nurses believe the clinically effective SpiroTimer™ helps both patients and nurses and should become part of routine care.

Highlights

  • To address the problem of incentive spirometry (IS) noncompliance, a use-tracking IS reminder device (SpiroTimerTM) was developed

  • This study aims to evaluate the SpiroTimerTM’s human factors as they pertain to intended users, use environments, and uses

  • The nurses felt that the SpiroTimerTM improved IS effectiveness (74%; 37/50, p < 0.001), as well as patient engagement in their own care (88%; 44/ 50, p < 0.001)

Read more

Summary

Introduction

To address the problem of IS noncompliance, a use-tracking IS reminder device (SpiroTimerTM) was developed and clinically tested in a recent large randomized clinical trial [6]. In the recent randomized controlled trial published in JAMA Surgery [6], patients undergoing coronary artery bypass grafting surgery were randomized to receive the SpiroTimerTM with the reminder bell turned off or on. Those with the bell turned on were found to have improved IS compliance, reduced mean atelectasis severity scores, lowered patient length of stay at the hospital, and reduced six-month mortality [6]. The SpiroTimerTM demonstrated significant cost- and life-saving benefits

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call